Schiller USA

Blog by Adriana

Impact of COVID-19 on exercise pathophysiology
Hospital survival in case of severe COVID-19 involvement is often associated with residual fibrotic lung abnormalities, evidenced by pulmonary CT at the time of discharge, and lung function tests.
27.04.21 04:40 PM - Comment(s)
Similarities between the Spanish influenza epidemic and COVID-19 
Is there anything in common between the pandemic we are currently confronting and previous pandemics?
05.04.21 09:38 PM - Comment(s)
Endotypical COPD treatment
COPD and its exacerbations are a serious health problem. COPD is the third leading cause of death worldwide. According to a study entitled
25.03.21 11:05 PM - Comment(s)
Francesco Iacona, CEO of Schiller Americas, named 2021 Miami-Dade Chair for the American Heart Association.

2020 was a year of uncertainty due to COVID-19. In 2021 we are still confronting uncertainty and the challenges of limitations on so many things, but saving lives must not be one of them. 

Over the past few years, Schiller Americas has been a proud partner of the American Heart Association, an a...

18.03.21 07:35 PM - Comment(s)
Spirometry, an underestimated test
Although dyspnea is a common reason for consulting a primary care physician (1 - 4% of all visits) pulmonary function tests are often overlooked and seldom performed
01.03.21 03:10 PM - Comment(s)